Expert Opinion on Drug Safety, Volume 17, Issue 6 (2018)

Browse this journal
Sample our Bioscience journals, sign in here to start your access, Latest two full volumes FREE to you for 14 days

Expert Opinion on Drug Safety, Volume 17, Issue 6 (2018)

See all volumes and issues
Vol 23, 2024 Vol 22, 2023 Vol 21, 2022 Vol 20, 2021 Vol 19, 2020 Vol 18, 2019 Volume 17, 2018 Vol 16, 2017 Vol 15, 2016 Vol 14, 2015 Vol 13, 2014 Vol 12, 2013 Vol 11, 2012 Vol 10, 2011 Vol 9, 2010 Vol 8, 2009 Vol 7, 2008 Vol 6, 2007 Vol 5, 2006 Vol 4, 2005 Vol 3, 2004 Vol 2, 2003 Vol 1, 2002
Download citations Download PDFs Download issue

Editorial

Editorial
How to address the placebo response in the prescription SSRIs and SNRIs in children and adolescents
Helen Koechlin, Joe Kossowsky, Jens Gaab & Cosima Locher
Pages: 537-540
Published online: 21 May 2018
AbstractforHow to address the placebo response in the prescription SSRIs and SNRIs in children and adolescents | Full Text | References | PDF (581.5 KB)
  • 1413 Views
  • 3 CrossRef citations
  • 0Altmetric
Free Access
Editorial
Nocebo effects: more investigation is needed
Fabrizio Benedetti & Aziz Shaibani
Pages: 541-543
Published online: 16 May 2018
First Page PreviewforNocebo effects: more investigation is needed | Full Text | References | PDF (310.9 KB)
  • 2030 Views
  • 10 CrossRef citations
  • 0Altmetric
Free Access

Original Research

Article
A comparison of approaches to identify possible cases of local anesthetic systemic toxicity in the FDA Adverse Event Reporting System (FAERS) database
Simon Dagenais, Richard Scranton, Andrew R. Joyce & Catherine C. Vick
Pages: 545-552
Published online: 10 May 2018
AbstractforA comparison of approaches to identify possible cases of local anesthetic systemic toxicity in the FDA Adverse Event Reporting System (FAERS) database | Full Text | References | PDF (692.6 KB) | Supplemental
  • 2282 Views
  • 7 CrossRef citations
  • 0Altmetric
Free Access
Article
Posology adjustments of oral antineoplastic agents for special populations: patients with renal impairment, hepatic impairment and hematologic toxicities
Julieta González, Matías Quiroga, Vicente Escudero-Vilaplana, Roberto Collado-Borrell, Ana Herranz-Alonso & María Sanjurjo Sáez
Pages: 553-572
Published online: 28 May 2018
AbstractforPosology adjustments of oral antineoplastic agents for special populations: patients with renal impairment, hepatic impairment and hematologic toxicities | Full Text | References | PDF (1.3 MB)
  • 309 Views
  • 8 CrossRef citations
  • 0Altmetric
Article
Experience with Sunitinib in metastatic renal cell carcinoma (mRCC) patients: pooled analysis from 3 Spanish observational prospective studies
Daniel Castellano, José Pablo Maroto, Enrique Espinosa, Enrique Grande, M Victoria Bolós, Julia Llinares, Emilio Esteban, Aranzazu González del Alba, Miguel Angel Climent, Jose Angel Arranz, Mª José Méndez, Eva Fernández Parra, Luis Antón-Aparicio, Cristina Bayona, Isabel Gallegos, Enrique Gallardo, Luz Samaniego & Jesús García Donas
Pages: 573-579
Published online: 28 Aug 2017
AbstractforExperience with Sunitinib in metastatic renal cell carcinoma (mRCC) patients: pooled analysis from 3 Spanish observational prospective studies | Full Text | References | PDF (698.7 KB)
  • 256 Views
  • 2 CrossRef citations
  • 0Altmetric
Article
Local anesthetics systemic toxicity association with exparel (bupivacaine liposome)- a pharmacovigilance evaluation
Nitish Aggarwal
Pages: 581-587
Published online: 05 Jun 2017
AbstractforLocal anesthetics systemic toxicity association with exparel (bupivacaine liposome)- a pharmacovigilance evaluation | Full Text | References | PDF (571.5 KB)
  • 975 Views
  • 27 CrossRef citations
  • 0Altmetric

Review

Review
The safety of dual bronchodilation on cardiovascular serious adverse events in COPD
Paola Rogliani, Josuel Ora, Maria Gabriella Matera, Mario Cazzola & Luigino Calzetta
Pages: 589-596
Published online: 14 May 2018
AbstractforThe safety of dual bronchodilation on cardiovascular serious adverse events in COPD | Full Text | References | PDF (948.4 KB)
  • 333 Views
  • 10 CrossRef citations
  • 0Altmetric
Review
Current and potential treatment options for hyperphosphatemia
Fabio Carfagna, Lucia Del Vecchio, Giuseppe Pontoriero & Francesco Locatelli
Pages: 597-607
Published online: 21 May 2018
AbstractforCurrent and potential treatment options for hyperphosphatemia | Full Text | References | PDF (922.4 KB)
  • 642 Views
  • 18 CrossRef citations
  • 0Altmetric
Review
A safety profile of medications used to treat Waldenström’s macroglobulinemia
Ramón García-Sanz, Cristina Jiménez, Verónica González De La Calle & María Eugenia Sarasquete
Pages: 609-621
Published online: 06 Jun 2018
AbstractforA safety profile of medications used to treat Waldenström’s macroglobulinemia | Full Text | References | PDF (1.4 MB)
  • 264 Views
  • 2 CrossRef citations
  • 0Altmetric
Review
Intolerance to tyrosine kinase inhibitors in chronic myeloid leukemia: the possible role of ponatinib
Massimo Breccia, Fabio Efficace, Alessandra Iurlo, Luigiana Luciano, Elisabetta Abruzzese, Antonella Gozzini, Patrizia Pregno, Mario Tiribelli, Gianantonio Rosti & Giorgio Minotti
Pages: 623-628
Published online: 30 May 2018
AbstractforIntolerance to tyrosine kinase inhibitors in chronic myeloid leukemia: the possible role of ponatinib | Full Text | References | PDF (820.4 KB)
  • 515 Views
  • 8 CrossRef citations
  • 0Altmetric

Original Research

Article
Analyzing research trends on drug safety using topic modeling
Chen Zou
Pages: 629-636
Published online: 06 Apr 2018
AbstractforAnalyzing research trends on drug safety using topic modeling | Full Text | References | PDF (906.3 KB)
  • 413 Views
  • 27 CrossRef citations
  • 0Altmetric

Drug Safety Evaluation

Article
The safety of indacaterol for the treatment of COPD
Evgenios I. Metaxas & Evangelos Balis
Pages: 637-642
Published online: 09 May 2018
AbstractforThe safety of indacaterol for the treatment of COPD | Full Text | References | PDF (525.1 KB)
  • 352 Views
  • 8 CrossRef citations
  • 0Altmetric
Article
The safety of trifluridine and tipiracil for the treatment of metastatic colorectal cancer
Julia Martinez-Perez, M. Carmen Riesco-Martinez & Rocio Garcia-Carbonero
Pages: 643-650
Published online: 23 May 2018
AbstractforThe safety of trifluridine and tipiracil for the treatment of metastatic colorectal cancer | Full Text | References | PDF (762.7 KB)
  • 283 Views
  • 3 CrossRef citations
  • 0Altmetric

Letter to the Editor

Letter
Letter to the Editor: androgenetic alopecia; drug safety and therapeutic strategies
Gary Ong, Michael Manyak & Zrinka Lulic
Pages: 651-652
Published online: 09 May 2018
CitationforLetter to the Editor: androgenetic alopecia; drug safety and therapeutic strategies | Full Text | References | PDF (254.2 KB)
  • 887 Views
  • 0 CrossRef citations
  • 0Altmetric
Free Access
Letter
Response to the letter to the editor; Androgenetic alopecia; drug safety and therapeutic strategies
Ion G. Motofei & David L. Rowland
Page: 653
Published online: 02 May 2018
CitationforResponse to the letter to the editor; Androgenetic alopecia; drug safety and therapeutic strategies | Full Text | References | PDF (231.7 KB)
  • 658 Views
  • 0 CrossRef citations
  • 0Altmetric
Free Access

Addendum

Addendum
Addendum
Page: 655
Published online: 08 Mar 2018
CitationforAddendum | Full Text | PDF (98.2 KB)
  • 30 Views
  • 0 CrossRef citations
  • 0Altmetric

Explore articles